Patent Licensing

What It Means

Patent licensing is the practice of granting permission to another party to make, use, or sell a patented invention in exchange for payment, typically in the form of royalties (a percentage of sales) or a lump-sum licensing fee. Licensing allows patent holders to monetize their intellectual property without manufacturing products themselves, and allows licensees to use patented technology without developing it from scratch. Licensing agreements vary widely in scope and structure. Exclusive licenses grant rights to a single licensee, while non-exclusive licenses allow the patent holder to grant the same rights to multiple parties. Field-of-use restrictions can limit the licensee to specific markets or applications. Geographic restrictions can limit use to certain countries or regions. Cross-licensing agreements, where two companies grant each other access to their respective patent portfolios, are common in industries with dense patent landscapes like semiconductors and telecommunications. Major technology companies often hold cross-licenses with dozens of competitors, creating a web of mutual access that allows the industry to function despite overlapping patent claims. Patent licensing generates substantial revenue for some companies: Qualcomm earns billions annually from licensing its wireless technology patents, and IBM historically generated over $1 billion per year from patent licensing. For patent portfolio holders, licensing revenue is a key metric that demonstrates the commercial value of their intellectual property. In pharmaceutical contexts, licensing agreements between brand-name and generic manufacturers — sometimes called "authorized generic" deals — can structure the transition when patents expire.

Frequently Asked Questions